Cargando…

Direct-acting antiviral agents in the therapy of hepatitis C virus-related mixed cryoglobulinaemia: a single-centre experience

BACKGROUND: The efficacy and safety of direct-acting antiviral agents (DAAs) were evaluated in a cohort of prospectively enrolled patients with hepatitis C virus (HCV)-related mixed cryoglobulinaemia (MC), an immune complex-mediated vasculitis of small and medium vessels in which the pathogenetic ro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lauletta, Gianfranco, Russi, Sabino, Pavone, Fabio, Vacca, Angelo, Dammacco, Franco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5385046/ https://www.ncbi.nlm.nih.gov/pubmed/28388935 http://dx.doi.org/10.1186/s13075-017-1280-6

Ejemplares similares

Assessment of total hepatitis C virus (HCV) core protein in HCV-related mixed cryoglobulinemia
por: Russi, Sabino, et al.
Publicado: (2014)

Mixed cryoglobulinaemia vasculitis after sustained hepatitis C virological response with direct-acting antivirals
por: Barbieri, Diego, et al.
Publicado: (2018)

Impact of Cryoglobulinemic Syndrome on the Outcome of Chronic Hepatitis C Virus Infection: A 15-Year Prospective Study
por: Lauletta, Gianfranco, et al.
Publicado: (2013)

The wide spectrum of cryoglobulinemic vasculitis and an overview of therapeutic advancements
por: Dammacco, Franco, et al.
Publicado: (2022)

Hepatitis C Virus Infection and Mixed Cryoglobulinemia
por: Lauletta, Gianfranco, et al.
Publicado: (2012)

Thymic stromal lymphopoietin in hepatitis C virus-related cryoglobulinemic vasculitis: gene expression level and protein distribution
por: Sansonno, Domenico, et al.
Publicado: (2015)

Direct-acting antiviral therapy improves kidney survival in hepatitis C virus-associated cryoglobulinaemia: the RENALCRYOGLOBULINEMIC study
por: Pérez de José, Ana, et al.
Publicado: (2020)

Successful Treatment of Cryoglobulinaemia with Rituximab
por: Choudhry, M., et al.
Publicado: (2012)

A Case of Cutaneous Vasculitis with Underlying Hepatitis C and Cryoglobulinaemia
por: Groves, Cheryl, et al.
Publicado: (2008)

Mixed Cryoglobulinaemia Vasculitis Treated with Obinutuzumab in a Patient Allergic to Rituximab
por: Gaudêncio, Margarida, et al.
Publicado: (2021)

AZD-1222/tozinameran: Flares of mixed cryoglobulinaemia vasculitis: 6 case reports
Publicado: (2022)

Cryoglobulinaemia in Egyptian Patients with Extrahepatic Cutaneous Manifestations of Chronic Hepatitis C Virus Infection
por: Hegab, Doaa Salah, et al.
Publicado: (2015)

An interesting rash: leucocytoclastic vasculitis with type 2 cryoglobulinaemia
por: Mannu, Gurdeep Singh
Publicado: (2010)

54. Type I cryoglobulinaemia: vascular occlusion and thrombosis
por: Zacharias, Hannah, et al.
Publicado: (2018)

Assessing the Safety of Direct-Acting Antiviral Agents for Hepatitis C
por: McGlynn, Elizabeth A., et al.
Publicado: (2019)

Fibrillary comma-shaped electron-dense organized glomerular deposits associated with cryoglobulinaemia
por: Stabellini, Nevio, et al.
Publicado: (2008)

Delayed surgical strategy for type A aortic dissection associated with acute hepatitis C cryoglobulinaemia
por: Ahmed-Issap, Amber, et al.
Publicado: (2022)

PB2549: CO-EXISTENT COLD AGGLUTININ DISEASE AND CRYOGLOBULINAEMIA
por: Japzon, Nicole, et al.
Publicado: (2023)

Hepatitis-Induced Porphyria: Are Direct-Acting Antiviral Agents the Way of the Future?
por: John, Jason J., et al.
Publicado: (2021)

Direct-acting Antivirals and Host-targeting Agents against the Hepatitis A Virus
por: Kanda, Tatsuo, et al.
Publicado: (2015)

Direct-acting Antiviral Agents for the Treatment of Chronic Hepatitis C Virus Infection
por: Kanda, Tatsuo, et al.
Publicado: (2014)

Therapy with Direct-Acting Antiviral Agents for Hepatitis C-Related Liver Cirrhosis
por: Toshikuni, Nobuyuki
Publicado: (2017)

Direct-acting antiviral agents against hepatitis C virus and lipid metabolism
por: Kanda, Tatsuo, et al.
Publicado: (2017)

Reactivation of herpesvirus in patients with hepatitis C treated with direct-acting antiviral agents
por: Ghweil, Ali A, et al.
Publicado: (2019)

IP-10 Interferes With the Antiviral Response of Direct-Acting Antiviral Agents for Hepatitis C Virus Infection
por: Wang, Yadong, et al.
Publicado: (2022)

Heavy-Chain Diseases and Myeloma-Associated Fanconi Syndrome: an Update
por: Ria, Roberto, et al.
Publicado: (2018)

Hepatitis B virus-associated cryoglobulinaemia diffuse endocapillary proliferative glomerulonephritis: a case report and literature review
por: Xu, Weiying, et al.
Publicado: (2022)

Predictive factors of renal involvement in cryoglobulinaemia: a retrospective study of 153 patients
por: Coliche, Vladimir, et al.
Publicado: (2018)

Hepatitis C Virus Cell-Cell Transmission and Resistance to Direct-Acting Antiviral Agents
por: Xiao, Fei, et al.
Publicado: (2014)

Treatment of hepatitis C virus genotype 3 infection with direct-acting antiviral agents
por: Zanaga, L.P., et al.
Publicado: (2016)

Hypozincemia in Chronic Hepatitis C Is Improved with Viral Clearance by Direct-acting Antiviral Agents
por: Shirahashi, Ryosaku, et al.
Publicado: (2021)

Factors Associated with the Refusal of Direct-Acting Antiviral Agents for the Treatment of Hepatitis C in Taiwan
por: Chang, Li-Jen, et al.
Publicado: (2022)

The Impact of Direct-Acting Antiviral Agents on Cytomegalovirus Reactivation in Chronic Hepatitis C Infection
por: Dawood, Reham M, et al.
Publicado: (2022)

Interferon-Free Regimens and Direct-Acting Antiviral Agents for Delta Hepatitis: Are We There Yet?
por: Nemteanu, Roxana, et al.
Publicado: (2023)

Barriers to care for chronic hepatitis C in the direct-acting antiviral era: a single-centre experience
por: Nguyen, Peter, et al.
Publicado: (2017)

Common Variable Immunodeficiency and Gastric Malignancies
por: Leone, Patrizia, et al.
Publicado: (2018)

Pharmacogenetics of hepatitis C: transition from interferon-based therapies to direct-acting antiviral agents
por: Kamal, Sanaa M
Publicado: (2014)

SASLT Position Statement on the Direct-Acting Antiviral Agents for the Treatment of Hepatitis C Virus Infection
por: Alghamdi, Abdullah S., et al.
Publicado: (2015)

Hepatitis C in healthcare personnel: secondary data analysis of therapies with direct-acting antiviral agents
por: Westermann, Claudia, et al.
Publicado: (2018)

Use of direct-acting antiviral agents in hepatitis C virus-infected liver transplant candidates
por: Gadiparthi, Chiranjeevi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_76vefnse443o4pjish0pjhrnle